Crystal structure of (E)-7-fluoro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C₂₁H₂₂FN₃O

Q: What type of study is this?

This is a X-ray diffraction study (also classified as: structure analysis).

Yu Chen; Wenjie Zhu; Wenxuan Li; Yan Ren; Gui‐Ge Hou

doi:10.1515/ncrs-2025-0256

July 25, 2025Zeitschrift für Kristallographie - New Crystal StructuresOpen Access

Crystal structure of (E)-7-fluoro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C₂₁H₂₂FN₃O

View Full Paper

Ask AI

Bookmark

Share

Key Points

Crystal structure of C21H22FN3O determined, revealing key geometric parameters.
Monoclinic space group P21/c identified with a cell volume of 1781.29 Å3.
Analyzed crystal data includes a = 17.2795 Å, b = 6.1659 Å, c = 16.7198 Å.
Low R factors indicate a reliable structural model for further studies.

Implication

X-ray diffraction reveals the monoclinic structure for C21H22FN3O, suggesting potential applications in medicinal chemistry.

Abstract

C 21 H 22 FN 3 O, monoclinic, P 2 1 / c (no. 14), a = 17.2795(3) Å, b = 6.1659(1) Å, c = 16.7198(3) Å, β = 90.596(1)°, V = 1781.29(5) Å 3 , Z = 4, R gt ( F ) = 0.0408, wR ref ( F 2 ) = 0.1122, T = 293 K.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/68c1afb954b1d3bfb60e7162 https://doi.org/10.1515/ncrs-2025-0256

View Full Paper

Ask AI

Bookmark

Share

Crystal structure of (E)-7-fluoro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C₂₁H₂₂FN₃O

Key Points

Implication

Abstract

Discussion

Cite This Study

Crystal structure of (E)-7-fluoro-2-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C₂₁H₂₂FN₃O

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading